Quidel Corporation (QDEL)
Quidel Corporation is a healthcare equipment and supplies company listed on the NASDAQ under the ticker QDEL. Through its diagnostic-testing businesses, the company develops and markets instruments and tests used in clinical chemistry, immunoassay, transfusion medicine, point-of-care testing, and molecular diagnostics. Its products are used to help detect disease, support patient management, screen blood and plasma donors, and identify infectious diseases across a range of care settings. Quidel sells directly to end users and also works through distributors, serving physicians’ offices, hospitals, clinical laboratories, urgent care clinics, universities, retail clinics, pharmacies, blood banks, and donor centers. The company has operations in North America, Europe, the Middle East, Africa, China, Japan, Asia Pacific, and Latin America. Quidel was incorporated in 1979 and is based in San Diego, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-QDEL
|
$20.62
|
27.1% Upside
|
Undervalued
|
$20.50
|
26.4% Upside
|
Undervalued
|
Fair
|
—
|
—
|
—
|
0.0%
|
July 30, 2026
|
-0.9x
|
0.6x
|
0.4x
|
1.131 B
|
3.845 B
|
71.8%
|
91.1%
|
0.8
|
—
|
13.2%
|